Daptomycin: a comparison of two intravenous formulations
Celeste Frankenfeld, Sachin Mittal, Yanira Melendez, Luke Mendez-Vigo, Kenneth C Lamp, Kaitlin N Keller, Shellie R Bertolami Merck & Co., Inc., Kenilworth, NJ, USA Abstract: Daptomycin is a cyclic lipopeptide antibacterial agent with potent bactericidal activity against a broad range of Gram-pos...
Saved in:
Main Authors: | Frankenfeld C (Author), Mittal S (Author), Melendez Y (Author), Mendez-Vigo L (Author), Lamp KC (Author), Keller KN (Author), Bertolami SR (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2018-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Population pharmacokinetics of intravenous daptomycin in critically ill patients: implications for selection of dosage regimens
by: Jianhua Wu, et al.
Published: (2024) -
A green approach for the quantification of daptomycin in pharmaceutical formulation by UV spectrophotometry
by: Eliane Gandolpho Tótoli, et al.
Published: (2015) -
Implementation and Comparison of Two Pharmacometric Tools for Model-Based Therapeutic Drug Monitoring and Precision Dosing of Daptomycin
by: Justine Heitzmann, et al.
Published: (2022) -
A fully validated microbiological assay for daptomycin injection and comparison to HPLC method
by: Ana Paula Christ, et al.
Published: (2015) -
Pharmacokinetics and skin-tissue penetration of daptomycin in rats
by: Matsumoto K, et al.
Published: (2015)